Pluvicto (lutetium LU 177 vipivotide tetraxetan)
Ended Awarded Last action
- Contract number
- 36C25524N0203
- Awardee
-
Advanced Accelerator Applications USA Inc. UEI JNM4NBNHFE66
- Awarding agency
-
Veterans Integrated Service Network 15
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $429,198
Award facts
- Contract value 100% obligated
- $429,198.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Millburn, NJ 07041, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$317,412 | |
| Original award | $746,610 |
About this award
Advanced Accelerator Applications USA Inc., a Novartis subsidiary specializing in radiopharmaceutical products, received a $429,198.13 firm fixed-price Blanket Purchase Agreement call from the Department of Veterans Affairs' Veterans Integrated Service Network 15 on April 4, 2024. The contract calls for the supply of PLUVICTO (lutetium Lu 177 vipivotide tetraxetan), an advanced nuclear medicine product used for targeted radioligand therapy in cancer treatment. The award is positioned under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not utilize a small business set-aside designation. Performance will take place in Millburn, New Jersey, with an ultimate completion date of March 27, 2025.
This BPA call represents part of Advanced Accelerator Applications USA Inc.'s broader engagement with federal healthcare agencies in supplying specialized radiopharmaceutical solutions. The company maintains substantial existing contract relationships across the VA system, Defense Health Agency, and National Institutes of Health, with several larger BPAs and Indefinite Delivery Contracts exceeding $1 million each. The award supports the VA's nuclear medicine and oncology programs by ensuring access to critical diagnostic and therapeutic radiopharmaceutical products across its medical center network.
Quick answers
Who was awarded contract 36C25524N0203?
36C25524N0203 was awarded to Advanced Accelerator Applications USA Inc. by Veterans Integrated Service Network 15 (Veterans Health Administration) on April 4, 2024.
How much is contract 36C25524N0203 worth?
The government has obligated $429,198 on 36C25524N0203.
Is contract 36C25524N0203 an order under another contract?
Yes. 36C25524N0203 is a BPA call under 36F79719D0169-36C25524A0025, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25524N0203 competed?
The extent of competition for 36C25524N0203 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award